OTLK Earnings

Quarterly EPS
$0.24
Q4 2024
$0.72
Q1 2025
$-1.50
Q2 2025
$-0.55
Q3 2025
$0.00
Q4 2025
$-0.38
Q1 2026
$-0.05
Q2 2026
$-0.15
Q3 2026
Latest Revenue8.7K
Latest Net Income-20319272
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.158.7K-20319272-99.4%+72.7%
Q2 2026-$0.05127.4K-4453081+96.7%
Q1 2026-$0.38-1207833-23058135-152.8%
Q4 2025
Q3 2025-$0.551.5M-20152502-128.8%
Q2 2025-$1.500-46357206+81.3%
Q1 2025$0.72017.4M+183.7%
Q4 2024$0.2405.7M+168.6%
Q3 2024$1.91044.4M
Q2 2024-$8.010-114288943
Q1 2024-$0.860-11178239
Q4 2023-$0.350-12990761
Outlook Therapeutics (OTLK) — Earnings